Pain Progression at Initiation of Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Post Hoc Analysis of the PROSELICA Study

SIMPLE SUMMARY: Despite the emergence of new therapies during the last decade, metastatic castration-resistant prostate cancer (mCRPC) remains fatal. Recent work showed that the timing of treatment initiation seems critical for patient outcomes. Thus, it is key to identify factors that can help in d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancers (Basel)
Hauptverfasser: Delanoy, Nicolas, Robbrecht, Debbie, Eisenberger, Mario, Sartor, Oliver, de Wit, Ronald, Mercier, Florence, Geffriaud-Ricouard, Christine, de Bono, Johann, Oudard, Stéphane
Format: Artigo
Sprache:Inglês
Veröffentlicht: MDPI 2021
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8002173/
https://ncbi.nlm.nih.gov/pubmed/33805793
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13061284
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge